Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts.
about
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicityRGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathwayDopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process.Association of RGS2 and RGS5 variants with schizophrenia symptom severity.Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.Prenatal L-DOPA exposure produces lasting changes in brain dopamine content, cocaine-induced dopamine release and cocaine conditioned place preferenceComplex network-driven view of genomic mechanisms underlying Parkinson's disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigraComparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization.Pleiotropic effects of neurotransmission during development: modulators of modularityRGS17: an emerging therapeutic target for lung and prostate cancers.Drugs, biogenic amine targets and the developing brainRegulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers.Control of striatal signaling by g protein regulators.CNS genes implicated in relapseCodelink: an R package for analysis of GE healthcare gene expression bioarrays.Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.
P2860
Q24296968-8A789F1E-9496-46AB-B786-5C098867C908Q27865228-FA331974-9B27-4FAF-8C78-9A120B7890A9Q30488917-DC292B1E-4310-4C16-ABAE-D4F9810E33B7Q33319041-24B2FAFD-9E1D-4135-864E-B402179F52E5Q34335443-80EF93C0-C6AB-41F5-A3D9-19F6131316A0Q34459380-F4D3064F-A3BC-43FB-8F27-E7BE025C15DFQ34667486-737816C0-CCF7-4B42-A258-3714580D0369Q36981184-CB696ED0-1C37-464B-9622-5CA81332641AQ37224539-0F8BD29B-C127-4979-B133-07EB6FB22539Q37398369-B6FD0316-75A2-460B-8CE2-AE92C29AEF88Q37446637-9BEDC032-68D5-4169-96B4-71BBE9BA33EDQ37600394-70E8EEB5-9F35-42C9-A2B9-1B66D5C0E373Q37919731-FDF51764-0D8E-4F44-9EE7-1DB26DC9855FQ38448419-5292025B-9DC4-4FE4-8A74-3CA8E84E19A7Q42613932-B770B29D-82A9-4BF6-A8E2-F53F1A0E72D2Q46696089-3287FEAA-7E7D-405A-A343-A19DC24F9C29
P2860
Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Genetic or pharmacological ina ...... signalling (Rgs) transcripts.
@en
Genetic or pharmacological ina ...... ulator of G-protein signalling
@nl
type
label
Genetic or pharmacological ina ...... signalling (Rgs) transcripts.
@en
Genetic or pharmacological ina ...... ulator of G-protein signalling
@nl
prefLabel
Genetic or pharmacological ina ...... signalling (Rgs) transcripts.
@en
Genetic or pharmacological ina ...... ulator of G-protein signalling
@nl
P2860
P1476
Genetic or pharmacological ina ...... signalling (Rgs) transcripts.
@en
P2093
Joshua P Parlaman
Pat Levitt
P2860
P304
P356
10.1111/J.1460-9568.2006.04970.X
P407
P577
2006-08-01T00:00:00Z